Arkady Mandel
Fortuna: 90 876 $ al 30/06/2026
Fortuna: 90 876 $ al 30/06/2026
Arkady Mandel is currently the Director & Chief Scientific Officer at Theralase Technologies, Inc. He previously served as the Chief Executive Officer & Chief Scientific Officer at Theralase, Inc. He obtained his doctorate degree from Russian State Medical University in 1978.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/05/2026 | 493.889 ( 0,17 % ) | 90 876 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| THERALASE TECHNOLOGIES INC. | Director Técnico/Científico/I+D | 01/01/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Theralase, Inc.
Theralase, Inc. Medical SpecialtiesHealth Technology Designs and manufactures therapeutic medical laser systems | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Theralase, Inc.
Theralase, Inc. Medical SpecialtiesHealth Technology Designs and manufactures therapeutic medical laser systems | Health Technology |
Theralase Technologies, Inc.
Theralase Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures super-pulsed, cold laser technology and equipment | Health Technology |
Russian State Medical University
Russian State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.